Healthcare End Period Cash Flow vs Sale Purchase Of Stock Analysis
HCSG Stock | USD 11.93 0.25 2.14% |
Healthcare Services financial indicator trend analysis is much more than just examining Healthcare Services latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Healthcare Services is a good investment. Please check the relationship between Healthcare Services End Period Cash Flow and its Sale Purchase Of Stock accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Healthcare Services Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
End Period Cash Flow vs Sale Purchase Of Stock
End Period Cash Flow vs Sale Purchase Of Stock Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Healthcare Services End Period Cash Flow account and Sale Purchase Of Stock. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Healthcare Services' End Period Cash Flow and Sale Purchase Of Stock is -0.23. Overlapping area represents the amount of variation of End Period Cash Flow that can explain the historical movement of Sale Purchase Of Stock in the same time period over historical financial statements of Healthcare Services Group, assuming nothing else is changed. The correlation between historical values of Healthcare Services' End Period Cash Flow and Sale Purchase Of Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which End Period Cash Flow of Healthcare Services Group are associated (or correlated) with its Sale Purchase Of Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Sale Purchase Of Stock has no effect on the direction of End Period Cash Flow i.e., Healthcare Services' End Period Cash Flow and Sale Purchase Of Stock go up and down completely randomly.
Correlation Coefficient | -0.23 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
End Period Cash Flow
Sale Purchase Of Stock
Most indicators from Healthcare Services' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Healthcare Services current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Healthcare Services Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. At this time, Healthcare Services' Enterprise Value Over EBITDA is most likely to drop in the upcoming years. The Healthcare Services' current Enterprise Value Multiple is estimated to increase to 12.22, while Issuance Of Capital Stock is projected to decrease to roughly 27.6 K.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 226.9M | 193.8M | 214.7M | 225.5M | Total Revenue | 1.6B | 1.7B | 1.7B | 1.8B |
Healthcare Services fundamental ratios Correlations
Click cells to compare fundamentals
Healthcare Services Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Healthcare Services fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 722.6M | 785.0M | 777.5M | 718.3M | 790.7M | 830.2M | |
Short Long Term Debt Total | 11.6M | 11.4M | 11.3M | 33.1M | 36.2M | 20.5M | |
Other Current Liab | 125.4M | 110.0M | 126.7M | 95.7M | 101.5M | 106.6M | |
Total Current Liabilities | 148.7M | 162.3M | 191.1M | 178.6M | 216.9M | 227.8M | |
Total Stockholder Equity | 460.3M | 480.5M | 452.7M | 426.2M | 456.6M | 479.4M | |
Property Plant And Equipment Net | 28.8M | 26.6M | 28.1M | 23.0M | 28.8M | 30.2M | |
Net Debt | (15.7M) | (128.0M) | (59.5M) | 6.8M | (18.1M) | (19.0M) | |
Retained Earnings | 195.5M | 200.9M | 184.0M | 154.5M | 185.0M | 100.4M | |
Cash | 27.3M | 139.3M | 70.8M | 26.3M | 54.3M | 40.3M | |
Non Current Assets Total | 206.9M | 212.6M | 231.1M | 209.7M | 219.0M | 229.9M | |
Non Currrent Assets Other | 20.4M | 35.6M | 31.5M | 34.3M | 67.3M | 70.7M | |
Cash And Short Term Investments | 118.0M | 264.3M | 185.2M | 121.5M | 147.5M | 154.8M | |
Net Receivables | 340.9M | 255.5M | 293.4M | 336.8M | 383.5M | 402.7M | |
Common Stock Shares Outstanding | 74.6M | 74.8M | 75.0M | 74.4M | 74.3M | 69.2M | |
Liabilities And Stockholders Equity | 722.6M | 785.0M | 777.5M | 718.3M | 790.7M | 830.2M | |
Non Current Liabilities Total | 113.6M | 142.3M | 133.7M | 113.5M | 117.1M | 123.0M | |
Inventory | 36.5M | 31.6M | 26.0M | 21.2M | 18.5M | 17.5M | |
Other Current Assets | 56.8M | 21.0M | 41.8M | 29.2M | 22.2M | 20.4M | |
Other Stockholder Equity | 261.2M | 273.2M | 264.0M | 274.4M | 272.7M | 286.3M | |
Total Liab | 262.3M | 304.6M | 324.9M | 292.2M | 334.0M | 350.7M | |
Property Plant And Equipment Gross | 28.8M | 26.6M | 54.3M | 55.2M | 50.8M | 53.3M | |
Total Current Assets | 515.7M | 572.4M | 546.4M | 508.6M | 571.7M | 600.3M | |
Accumulated Other Comprehensive Income | 2.9M | 5.6M | 4M | (3.5M) | (1.8M) | (1.9M) | |
Short Term Debt | 10M | 5.3M | 6.5M | 25M | 28.8M | 18.9M | |
Intangible Assets | 22.4M | 18.2M | 20.8M | 15.9M | 12.1M | 10.4M | |
Accounts Payable | 54.4M | 52.2M | 64.4M | 68.3M | 83.2M | 87.4M | |
Common Stock Total Equity | 756K | 758K | 760K | 762K | 876.3K | 560.9K | |
Common Stock | 756K | 758K | 760K | 762K | 763K | 572.0K | |
Other Liab | 102.0M | 142.3M | 133.7M | 105.4M | 121.3M | 127.3M | |
Other Assets | 104.6M | 116.8M | 107.5M | 95.3M | 109.5M | 115.0M | |
Treasury Stock | (9.7M) | (9.4M) | (9.0M) | (30.2M) | (27.1M) | (25.8M) | |
Property Plant Equipment | 28.8M | 26.6M | 28.1M | 23.0M | 26.4M | 27.7M | |
Short Term Investments | 90.7M | 125.0M | 114.4M | 95.2M | 93.1M | 70.6M | |
Net Tangible Assets | 398.5M | 422.6M | 357.1M | 342.8M | 394.2M | 324.8M | |
Retained Earnings Total Equity | 195.5M | 200.9M | 184.0M | 154.5M | 177.7M | 153.3M | |
Capital Surpluse | 270.6M | 282.2M | 294.1M | 302.3M | 347.6M | 241.1M | |
Deferred Long Term Liab | 37.6M | 46.8M | 46.9M | 33.8M | 38.8M | 29.6M | |
Long Term Investments | 47.0M | 34.4M | 29.3M | 32.6M | 37.5M | 21.1M |
Currently Active Assets on Macroaxis
When determining whether Healthcare Services is a strong investment it is important to analyze Healthcare Services' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Healthcare Services' future performance. For an informed investment choice regarding Healthcare Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Healthcare Services Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Commercial Services & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthcare Services. If investors know Healthcare will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthcare Services listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.322 | Earnings Share 0.69 | Revenue Per Share 23.052 | Quarterly Revenue Growth 0.041 | Return On Assets 0.048 |
The market value of Healthcare Services is measured differently than its book value, which is the value of Healthcare that is recorded on the company's balance sheet. Investors also form their own opinion of Healthcare Services' value that differs from its market value or its book value, called intrinsic value, which is Healthcare Services' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthcare Services' market value can be influenced by many factors that don't directly affect Healthcare Services' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthcare Services' value and its price as these two are different measures arrived at by different means. Investors typically determine if Healthcare Services is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthcare Services' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.